Are you Dr. Ayash?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4100 John R St
Karmanos Cancer Inst
Detroit, MI 48201Phone+1 800-527-6266Fax+1 313-576-8767
Summary
- Dr. Lois Ayash, MD is an oncologist in Detroit, Michigan. She is currently licensed to practice medicine in Michigan and Massachusetts. She is affiliated with Karmanos Cancer Center, DMC Harper University Hospital, and DMC Detroit Receiving Hospital & University Health Center.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1988 - 1990
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1985 - 1988
St Vincent HospitalResidency, Internal Medicine, 1981 - 1984
University of Massachusetts Medical SchoolClass of 1981
Certifications & Licensure
MI State Medical License 1997 - 2026
MA State Medical License 1983 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Start of enrollment: 2007 Jan 01
- Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma Start of enrollment: 2015 Feb 12
- Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 4 citationsComparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation.Dipenkumar Modi, Seongho Kim, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn
Bone Marrow Transplantation. 2021-03-01 - 7 citationsA perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors.Lois Ayash, Karen H. Antman, Bruce D. Cheson
Oncology. 1991-03-01 - 9 citationsLiver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients.Dipenkumar Modi, Jing Christine Ye, Vijendra Singh, Wei Chen, Hyejeong Jang
American Journal of Hematology. 2019-07-10
Press Mentions
Graduating Fellow and Karmanos Breast Cancer Specialist Co-Author Manuscript on Triple Negative Breast Cancer with BMT FacultyOctober 18th, 2022
Grant Support
- Tetrathiomolybdate As Maintenance Therapy After Autologous Peripheral Stem CellNational Center For Research Resources2004–2005
Professional Memberships
- Member
